Our mission is to amplify the rare condition voice. One of the ways we achieve that is through collaborations across the community, from patients and caregivers to industry leaders in treatment research and development.
In this vein, Patient Worthy will publish sponsored rare disease content that impacts our community, on behalf of other organizations. We hope these efforts will achieve improved awareness, communication and engagement across the rare disease world.
Sponsored content ranges from promoting events on our events calendar, to publishing, curating or creating content on behalf of an organization. While we may promote events on behalf of an organization, we are not involved in the event planning or hosting, unless otherwise noted.
All sponsored and promotional content must embody our mission of providing relevant, vetted and valuable information to our rare disease audience. Any promotional collaboration will be highlighted in the post, with the name of the sponsoring organization. On social media, a collaboration will be indicated with #Collab.
To learn more about our collaborations, contact [email protected].
Latest Patient Worthy Articles
Heart Health Heroes Wanted: Join a Clinical Trial to Help Manage ATTR-CM
James Moore
February 18, 2025
Read More »
Spinogenix reports positive results in Phase 2 SPG601 trial for Fragile X Syndrome
Bree Clare
February 18, 2025
Read More »
The Importance of Who, What, When, Where, and How in Your Family Health History: How to get the most out of your genetic counselor
Patient Worthy Contributor
February 17, 2025
Read More »
Re-defining the Role of the Nurse Practitioner and Physician’s Assistant
Patient Worthy Contributor
February 14, 2025
Read More »
Genentech’s Gazyva drug has positive results in Phase III trial
Bree Clare
February 13, 2025
Read More »
Sierra Domb on Visual Snow Syndrome: A Journey of Resilience, Medical Trauma, and Advocacy
Bree Clare
February 12, 2025
Read More »
Idiopathic multicentric Castleman’s disease (iMCD) treatment found by AI tool
Bree Clare
February 11, 2025
Read More »